Xtant Medical Holdings Inc


Prices are adjusted according to historical splits.

Xtant Medical Holdings Inc Stock Price


Today's Low:
Today's High:
Open Price:
52W Low:
52W High:
Prev. Close:

Company Statistics

Market Cap.:
$0.073 billion
Book Value:
Revenue TTM:
$0.056 billion
Operating Margin TTM:
Gross Profit TTM:
$0.032 billion
Gross Profit TTM:
$0.032 billion
Profit Margin:
Return on Assets TTM:
Return on Equity TTM:

Company Profile

Xtant Medical Holdings Inc had its IPO on 2015-10-19 under the ticker symbol XTNT.

The company operates in the LIFE SCIENCES sector and (NO DISGNOSTIC SUBSTANCES) industry. Xtant Medical Holdings Inc has a staff strength of 0 employees.

Stock update

Shares of Xtant Medical Holdings Inc opened at $0.68 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $0.64 - $0.68, and closed at $0.67.

This is a +3.83% increase from the previous day's closing price.

A total volume of 7,915 shares were traded at the close of the day’s session.

In the last one week, shares of Xtant Medical Holdings Inc have slipped by -32.51%.

Xtant Medical Holdings Inc's Key Ratios

Xtant Medical Holdings Inc has a market cap of $0.073 billion, indicating a price to book ratio of 2.462 and a price to sales ratio of 1.312.

In the last 12-months Xtant Medical Holdings Inc’s revenue was $0.056 billion with a gross profit of $0.032 billion and an EBITDA of $-0.005 billion. The EBITDA ratio measures Xtant Medical Holdings Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Xtant Medical Holdings Inc’s operating margin was -11.2% while its return on assets stood at -6.99% with a return of equity of -25.8%.

In Q2, Xtant Medical Holdings Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 2%.

Xtant Medical Holdings Inc’s PE and PEG Ratio

Forward PE
Trailing PE

Its diluted EPS in the last 12-months stands at $-0.089 per share while it has a forward price to earnings multiple of - and a PEG multiple of -0.03. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Xtant Medical Holdings Inc’s profitability.

Xtant Medical Holdings Inc stock is trading at a EV to sales ratio of 1.246 and a EV to EBITDA ratio of -13.19. Its price to sales ratio in the trailing 12-months stood at 1.312.

Xtant Medical Holdings Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio

Xtant Medical Holdings Inc ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Xtant Medical Holdings Inc ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Xtant Medical Holdings Inc’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Xtant Medical Holdings Inc's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Xtant Medical Holdings Inc paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
52-Week High
52-Week Low
Analyst Target Price

Xtant Medical Holdings Inc stock is currently trading at $0.67 per share. It touched a 52-week high of $1.17 and a 52-week low of $1.17. Analysts tracking the stock have a 12-month average target price of $1.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Xtant Medical Holdings Inc

The stock symbol (also called stock or share ticker) of Xtant Medical Holdings Inc is XTNT

The IPO of Xtant Medical Holdings Inc took place on 2015-10-19

Similar Industry Stocks ((NO DISGNOSTIC SUBSTANCES))

Last Price

Most Active

Last Price
Apple Inc (AAPL)

Top Gainers

Last Price

Top Losers

Last Price
Air T, Inc (AIRTW)


Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. The company is headquartered in Belgrade, Montana.